Your point is that you are manufacturing MSC, but have you studied the concerns in the manufacturing process?
Derived MSC come from healthy donors and manufactured cells have the ability to change.
I have concerns with IPSC becoming a safe MSC and research shows that.
- Forums
- ASX - By Stock
- CYP
- Paving the way for next-gen treatments
CYP
cynata therapeutics limited
Add to My Watchlist
2.78%
!
17.5¢

Paving the way for next-gen treatments, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.5¢ |
Change
-0.005(2.78%) |
Mkt cap ! $39.54M |
Open | High | Low | Value | Volume |
17.5¢ | 17.5¢ | 17.5¢ | $6.287K | 35.92K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 67866 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 42766 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 67866 | 0.170 |
3 | 70542 | 0.165 |
3 | 37975 | 0.160 |
5 | 207290 | 0.155 |
5 | 318045 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 42766 | 4 |
0.185 | 118641 | 4 |
0.190 | 40000 | 2 |
0.195 | 9983 | 3 |
0.200 | 62181 | 3 |
Last trade - 11.42am 29/07/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |